Example: bachelor of science
Search results with tag "Meiji seika pharma"
ur - meiji-seika-pharma.co.jp
www.meiji-seika-pharma.co.jpTitle: ur Author: Meiji Seika ファルマ株式会社 Created Date: 5/27/2021 1:56:30 PM
Major R&D Pipeline - eisai.com
www.eisai.comDevelopment progress from April 2018 onwards Reference Data [R&D Pipeline] 19 August 1, 2018 / Eisai Co., Ltd. Development Code: ME2125 Generic Name: safinamide Indications / Drug class: Anti-Parkinson's disease agent / MAO-B inhibitor In-license (Meiji Seika Pharma)